398 results on '"Haas, Carla"'
Search Results
2. Klebsiella LPS O1-antigen prevents complement-mediated killing by inhibiting C9 polymerization
3. Glycan-specific IgM is critical for human immunity to Staphylococcus aureus
4. Artificial surface labelling of Escherichia coli with StrepTagII antigen to study how monoclonal antibodies drive complement-mediated killing
5. Inhibition of cleavage of human complement component C5 and the R885H C5 variant by two distinct high affinity anti-C5 nanobodies
6. Not All Arms of IgM Are Equal: Following Hinge-Directed Cleavage by Online Native SEC-Orbitrap-Based CDMS
7. Agnostic B cell selection approach identifies antibodies against K. pneumoniae that synergistically drive complement activation
8. Glycan-specific IgM is critical for human immunity to Staphylococcus aureus
9. Klebsiella LPS O1-antigen prevents complement-mediated killing by inhibiting C9 polymerization
10. CD5L is a canonical component of circulatory IgM
11. 100 LPS O1-antigen-mediated complement-resistance of Klebsiella pneumoniae clinical isolates
12. Isolation and functional analysis of phage‐displayed antibody fragments targeting the staphylococcal superantigen‐like proteins
13. Glycan-specific IgM is critical for human immunity toStaphylococcus aureus
14. Human CD45 is an F-component-specific receptor for the staphylococcal toxin Panton–Valentine leukocidin
15. Artificial surface labelling of Escherichia coli with StrepTagII antigen to study how monoclonal antibodies drive complement-mediated killing
16. Promoting Fc-Fc interactions between anti-capsular antibodies provides strong immune protection against Streptococcus pneumoniae.
17. Promoting Fc-Fc interactions between anti-capsular antibodies provides strong immune protection against Streptococcus pneumoniae.
18. CD5L is a canonical component of circulatory IgM
19. Artificial surface labelling of Escherichia coli with StrepTagII antigen to study how monoclonal antibodies drive complement-mediated killing
20. Inhibition of cleavage of human complement component C5 and the R885H C5 variant by two distinct high affinity anti-C5 nanobodies
21. CD5L is a canonical component of circulatory IgM
22. Artificial surface labelling of Escherichia coli with StrepTagII antigen to study how monoclonal antibodies drive complement-mediated killing
23. Isolation and functional analysis of phage-displayed antibody fragments targeting the staphylococcal superantigen-like proteins
24. Promoting Fc-Fc interactions between anti-capsular antibodies provides strong immune protection against Streptococcus pneumoniae.
25. Promoting Fc-Fc interactions between anti-capsular antibodies provides strong immune protection against Streptococcus pneumoniae
26. Lugar: o espaço de vivência na geografia escolar para a formação cidadã
27. Glycan-Specific IgM Is Critical for Human Immunity to Staphylococcus aureus
28. Structural basis for inhibition of TLR2 by staphylococcal superantigen-like protein 3 (SSL3)
29. Author response: Promoting Fc-Fc interactions between anti-capsular antibodies provides strong immune protection against Streptococcus pneumoniae
30. Molecular basis determining species specificity for TLR2 inhibition by staphylococcal superantigen-like protein 3 (SSL3)
31. Toward Understanding How Staphylococcal Protein A Inhibits IgG-Mediated Phagocytosis
32. Antibody Recognition of Different Staphylococcus aureus Wall Teichoic Acid Glycoforms
33. Correction: Polymerization of C9 enhances bacterial cell envelope damage and killing by membrane attack complex pores
34. Monoclonal antibodies effectively potentiate complement activation and phagocytosis of Staphylococcus epidermidis in neonatal human plasma
35. Tips and Tricks from Staphylococcus Aureus
36. Human monoclonal antibodies against Staphylococcus aureus surface antigens recognize in vitro and in vivo biofilm
37. Toward Understanding How Staphylococcal Protein A Inhibits IgG-Mediated Phagocytosis
38. Correction: Polymerization of C9 enhances bacterial cell envelope damage and killing by membrane attack complex pores
39. Monoclonal antibodies effectively potentiate complement activation and phagocytosis of Staphylococcus epidermidis in neonatal human plasma
40. Toward Understanding How Staphylococcal Protein A Inhibits IgG-Mediated Phagocytosis
41. Human monoclonal antibodies against Staphylococcus aureus surface antigens recognize in vitro and in vivo biofilm
42. Staphylococcal protein A inhibits IgG-mediated phagocytosis by blocking the interaction of IgGs with FcγRs and FcRn
43. Promoting Fc-Fc interactions between anti-capsular antibodies provides strong immune protection against Streptococcus pneumoniae
44. Human monoclonal antibodies against Staphylococcus aureus surface antigens recognize in vitro and in vivo biofilm
45. Polymerization of C9 enhances bacterial cell envelope damage and killing by membrane attack complex pores
46. Promoting Fc-Fc interactions between anti-capsular antibodies provides strong immune protection against Streptococcus pneumoniae.
47. Author response: Human monoclonal antibodies against Staphylococcus aureus surface antigens recognize in vitro and in vivo biofilm
48. Polymerization of C9 enhances bacterial cell envelope damage and killing by membrane attack complex pores
49. Publisher Correction: Human CD45 is an F-component-specific receptor for the staphylococcal toxin Panton–Valentine leukocidin
50. Staphylococcal SSL5 inhibits leukocyte activation by chemokines and anaphylatoxins
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.